Development and Performance of Electronic Pediatric Risk of Mortality and Pediatric Logistic Organ Dysfunction-2

Christopher M Horvat1,2,3, Henry Ogoe3, Sajel Kantawala1,3

  • 1Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Insights

Electronic pediatric intensive care unit (PICU) scores, including the Pediatric Risk of Mortality-IV and Pediatric Logistic Organ Dysfunction-2, demonstrate strong predictive validity for hospital mortality. These validated scores can enhance quality improvement and research in PICUs.

Area of Science:

  • Pediatric critical care medicine
  • Health informatics
  • Clinical outcomes research

Background:

  • Pediatric Risk of Mortality-IV (PRISM-IV) and Pediatric Logistic Organ Dysfunction-2 (PELOD-2) scores are crucial for assessing pediatric intensive care unit (PICU) patient severity.
  • Electronic health records (EHRs) offer a potential platform for deriving these scores efficiently.
  • Validating electronic versions of these scores is essential for their reliable application in clinical practice and research.

Purpose of the Study:

  • To develop and evaluate the performance of electronic versions of the PRISM-IV and PELOD-2 scores.
  • To assess the predictive validity of these electronic scores for hospital mortality.
  • To determine the accuracy and calibration of electronically derived scores.

Main Methods:

  • A retrospective cohort study was conducted using structured EHR data from a quaternary PICU.
  • The study included 21,335 PICU encounters between January 1, 2009, and December 31, 2017.
  • Predictive validity was assessed using discrimination (AUC-ROC, AUC-PR) and calibration (Hosmer-Lemeshow test, standardized mortality ratio) after recalibration.

Main Results:

  • Electronic PRISM-IV and PELOD-2 scores showed strong agreement with prospectively calculated data.
  • Uncalibrated AUC-ROC values were 0.87 for electronic PRISM-IV and 0.96 for electronic PELOD-2.
  • Recalibrated models demonstrated acceptable goodness-of-fit, indicating reliable predictive performance.

Conclusions:

  • Electronically derived PRISM-IV and PELOD-2 scores exhibit excellent predictive validity for hospital mortality in the PICU.
  • These validated electronic scores can facilitate performance improvement initiatives and interinstitutional research.
  • The use of EHR data for acuity scoring offers a scalable strategy for PICU outcome comparisons.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
261
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
250
Piaget's Stage 2 of Cognitive Development01:14

Piaget's Stage 2 of Cognitive Development

The preoperational stage, the second of Jean Piaget's four stages of cognitive development, spans approximately ages 2 to 7 and is characterized by the emergence of symbolic thinking. During this stage, children use language, images, and symbols to represent objects and concepts, enabling them to engage in imaginative and pretend play. This symbolic thinking supports children's ability to perform make-believe actions, such as imagining a broom as a horse or their hand as a phone, blending...
875
Development of the Sexual Organs in the Embryo and Fetus01:15

Development of the Sexual Organs in the Embryo and Fetus

Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
3.4K